We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.71%
2 Healthcare 16.11%
3 Consumer Discretionary 15.3%
4 Communication Services 13.46%
5 Financials 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
1526
CytomX Therapeutics
CTMX
$721M
$4.36M ﹤0.01%
688,324
-1,007,942
-59% -$7.85M
STEL
1527
DELISTED
Stellar Bancorp
STEL
$4.33M ﹤0.01%
158,397
+108,595
+218% +$3.27M
ORI icon
1528
Old Republic International
ORI
$10.4B
$4.28M ﹤0.01%
171,969
+2,677
+2% +$67.2K
FHN icon
1529
First Horizon
FHN
$12.4B
$4.24M ﹤0.01%
245,135
-30,276
-11% -$550K
BYND icon
1530
Beyond Meat
BYND
$7.09B
$4.19M ﹤0.01%
887
-31
-3% -$124K
CCRN
1531
DELISTED
Cross Country Healthcare
CCRN
$4.18M ﹤0.01%
253,026
-2,124,186
-89% -$32.4M
HNI icon
1532
HNI Corp
HNI
$3.55B
$4.18M ﹤0.01%
94,980
-1,568
-2% -$68K
VVV icon
1533
Valvoline
VVV
$4.34B
$4.17M ﹤0.01%
128,443
-29,995
-19% -$933K
TD icon
1534
Toronto Dominion Bank
TD
$204B
$4.16M ﹤0.01%
59,334
+222
+0.4% +$15.5K
PII icon
1535
Polaris
PII
$3.92B
$4.15M ﹤0.01%
30,294
-1,196
-4% -$162K
EAF icon
1536
GrafTech
EAF
$200M
$4.13M ﹤0.01%
35,514
+32,889
+1,253% +$4.13M
COLD icon
1537
Americold
COLD
$4.29B
$4.12M ﹤0.01%
108,865
+7,216
+7% +$279K
KPTI icon
1538
Karyopharm Therapeutics
KPTI
$45.6M
$4.12M ﹤0.01%
26,607
-6,257
-19% -$908K
DBX icon
1539
Dropbox
DBX
$7.58B
$4.11M ﹤0.01%
135,644
-356,285
-72% -$9.73M
LAD icon
1540
Lithia Motors
LAD
$8.29B
$4.1M ﹤0.01%
11,929
-425
-3% -$154K
DLB icon
1541
Dolby
DLB
$5.82B
$4.09M ﹤0.01%
41,653
+4,249
+11% +$420K
FRBK
1542
DELISTED
Republic First Bancorp Inc
FRBK
$4.09M ﹤0.01%
1,024,692
+522,547
+104% +$2.1M
CADE
1543
DELISTED
Cadence Bancorporation
CADE
$4.04M ﹤0.01%
193,431
+72,392
+60% +$1.59M
ESXB
1544
DELISTED
Community Bankers Trust Corporation
ESXB
$4.04M ﹤0.01%
355,800
+158,901
+81% +$1.53M
PSMT icon
1545
Pricesmart
PSMT
$5.54B
$4.02M ﹤0.01%
44,190
-1,549
-3% -$138K
COHR icon
1546
Coherent
COHR
$63.1B
$4.01M ﹤0.01%
55,226
+631
+1% +$44.4K
FSLR icon
1547
First Solar
FSLR
$24.5B
$3.98M ﹤0.01%
43,954
-2,530
-5% -$200K
UL icon
1548
Unilever
UL
$134B
$3.95M ﹤0.01%
59,992
+9,741
+19% +$648K
ARWR icon
1549
Arrowhead Research
ARWR
$12B
$3.94M ﹤0.01%
47,539
-3,458
-7% -$257K
BJ icon
1550
BJs Wholesale Club
BJ
$12B
$3.93M ﹤0.01%
82,677
-6,677
-7% -$306K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.